Deep-insight reports for biopharma leaders
The Intelligence Vault -- our library of deep-insight reports covering market dynamics, clinical pipeline, and commercial implications for the therapeutic areas where we operate.
Therapeutic area deep-insight reports
Four focused reports aligned to our core therapeutic areas -- advanced metabolic, cardio-metabolic, cardio-renal, and rare metabolic conditions.
Advanced Metabolic & Obesity
GLP-1, dual/triple agonists, next-gen incretins, and branded obesity therapies -- market dynamics, pipeline, and commercial implications.
38 pages
Request Access →Cardio-Metabolic Outcomes & Value
Cardiovascular outcomes data, cardio-renal-metabolic risk narratives, and payer value frameworks for GLP-1 and next-gen metabolic assets.
42 pages
Request Access →Cardio-Renal & Metabolic Interfaces
SGLT2, GLP-1, and emerging cardio-renal-metabolic interplay -- payer evaluations, clinical positioning, and cross-indication strategy.
32 pages
Request Access →Rare Metabolic & Orphan Conditions
Rare endocrine, metabolic, and obesity-adjacent programs -- launch architecture and retention strategy for small-population therapies.
37 pages
Request Access →Want access to the Intelligence Vault?
Contact us to request reports or sign up for notifications when new video content is released.
Get in Touch →